Spear Matthew A. 4
4 · Poseida Therapeutics, Inc. · Filed Jul 30, 2021
Insider Transaction Report
Form 4
Spear Matthew A.
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-07-28−20,000→ 94,861 totalExercise: $1.32Exp: 2026-06-19→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-07-28$1.32/sh+20,000$26,440→ 41,485 total
Footnotes (1)
- [F1]The stock option is fully vested and exercisable.